MedTrace Logo

The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure

NCT00978653 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-09-22

No results posted yet for this study

Summary

In this prospective study, the investigators aimed to evaluate the effects of improved hyperuricemia, a minor cardiovascular risk factor, on endothelial dysfunction in patients with chronic kidney disease.

Conditions

Interventions

DRUG

allopurinol

150 mg once a day

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Berna Yelken, MD · Division of Nephrology, Istanbul Faculty of Medicine, Istanbul University

  • Yasar Caliskan · Division of Nephrology, Istanbul Faculty of Medicine, Istanbul University

  • Alaattin Yildiz, Prof, MD · Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University

  • Numan Gorgulu, MD · Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-03-31
Completion
2009-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00978653 on ClinicalTrials.gov